Towards Healthcare
AI in Precision Medicine Market Leads 25.54% CAGR by 2034

AI in Precision Medicine Market Growth Trajectory and Investment Opportunities

Based on market forecasts, the global AI in precision medicine market, projected at USD 2.74 billion in 2024, is expected to reach USD 26.66 billion by 2034, growing at a CAGR of 25.54% over the forecast period. AI is revolutionizing precision medicine by enabling faster, accurate results and supporting healthcare decisions with advanced insights. Backed by investments and favorable policies, it integrates genomic and non-genomic data, like symptoms and lifestyle, to personalize diagnoses and improve patient outcomes.

Introduction

  • Research Objective
  • Scope of the Study
  • Definition and Taxonomy

Research Methodology

  • Research Approach
  • Data Sources
  • Assumptions

Executive Summary

  • Synopsis
  • Analyst Recommendations

Market Overview 

  • Market Dynamics
    • Market Drivers
    • Market Restraints
    • Market Opportunities
  • Value Chain Analysis
    • Raw Material Sourcing
    • Manufacturing Process
    • Logistics & Transportation
    • Buyer Preferences
  • Trends
    • Market Trends
    • Technological Trends
  • Porter’s Five Forces Analysis
    • Bargaining Power of Suppliers
    • Bargaining Power of Buyers
    • Threat of Substitute
    • Threat of New Entrants
    • Degree of Competition
  • PESTLE Analysis for 5 Leading Countries
    • Regulatory Framework for Leading Countries/Regions
    • Supply Demand Analysis
    • Production & Consumption Statistics
    • Export Import Statistics
    • Price Trend Analysis

Global AI in Precision Medicine Market Assessment

  • Overview
  • Global AI in Precision Medicine Market Size Value (US$) and Volume (Billion Tons), by Technology (2021 – 2033)
    • Machine Learning
    • Querying Method
    • Deep Learning
    • Context-Aware Processing
    • Natural Language Processing
  • Global AI in Precision Medicine Market Size Value (US$) and Volume (Billion Tons), by Component (2021 – 2033)
    • Hardware
    • Software
    • Service
  • Global AI in Precision Medicine Market Size Value (US$) and Volume (Billion Tons), by Therapeutic Application (2021 – 2033)
    • Oncology
    • Neurology
    • Cardiology
    • Respiratory
    • Others
  • Global AI in Precision Medicine Market Size Value (US$) and Volume (Billion Tons), by Geography (2021 – 2033)
    • North America
    • Europe
    • Asia-Pacific
    • Latin America
    • The Middle East and Africa

North America AI in Precision Medicine Market Assessment

  • Overview
  • North America AI in Precision Medicine Market Size Value (US$) and Volume (Billion Tons), by Technology (2021 – 2033)
    • Machine Learning
    • Querying Method
    • Deep Learning
    • Context-Aware Processing
    • Natural Language Processing
  • North America AI in Precision Medicine Market Size Value (US$) and Volume (Billion Tons), by Component (2021 – 2033)
    • Hardware
    • Software
    • Service
  • North America AI in Precision Medicine Market Size Value (US$) and Volume (Billion Tons), by Therapeutic Application (2021 – 2033)
    • Oncology
    • Neurology
    • Cardiology
    • Respiratory
    • Others

Europe AI in Precision Medicine Market Assessment

  • Overview
  • Europe AI in Precision Medicine Market Size Value (US$) and Volume (Billion Tons), by Technology (2021 – 2033)
    • Machine Learning
    • Querying Method
    • Deep Learning
    • Context-Aware Processing
    • Natural Language Processing
  • Europe AI in Precision Medicine Market Size Value (US$) and Volume (Billion Tons), by Component (2021 – 2033)
    • Hardware
    • Software
    • Service
  • Europe AI in Precision Medicine Market Size Value (US$) and Volume (Billion Tons), by Therapeutic Application (2021 – 2033)
    • Oncology
    • Neurology
    • Cardiology
    • Respiratory
    • Others

Asia-Pacific AI in Precision Medicine Market Assessment

  • Overview
  • Asia-Pacific AI in Precision Medicine Market Size Value (US$) and Volume (Billion Tons), by Technology (2021 – 2033)
    • Machine Learning
    • Querying Method
    • Deep Learning
    • Context-Aware Processing
    • Natural Language Processing
  • Asia-Pacific AI in Precision Medicine Market Size Value (US$) and Volume (Billion Tons), by Component (2021 – 2033)
    • Hardware
    • Software
    • Service
  • Asia-Pacific AI in Precision Medicine Market Size Value (US$) and Volume (Billion Tons), by Therapeutic Application (2021 – 2033)
    • Oncology
    • Neurology
    • Cardiology
    • Respiratory
    • Others

Latin America AI in Precision Medicine Market Assessment

  • Overview
  • Latin America AI in Precision Medicine Market Size Value (US$) and Volume (Billion Tons), by Technology (2021 – 2033)
    • Machine Learning
    • Querying Method
    • Deep Learning
    • Context-Aware Processing
    • Natural Language Processing
  • Latin America AI in Precision Medicine Market Size Value (US$) and Volume (Billion Tons), by Component (2021 – 2033)
    • Hardware
    • Software
    • Service
  • Latin America AI in Precision Medicine Market Size Value (US$) and Volume (Billion Tons), by Therapeutic Application (2021 – 2033)
    • Oncology
    • Neurology
    • Cardiology
    • Respiratory
    • Others

The Middle East and Africa AI in Precision Medicine Market Assessment

  • Overview
  • The Middle East and Africa AI in Precision Medicine Market Size Value (US$) and Volume (Billion Tons), by Technology (2021 – 2033)
    • Machine Learning
    • Querying Method
    • Deep Learning
    • Context-Aware Processing
    • Natural Language Processing
  • The Middle East and Africa AI in Precision Medicine Market Size Value (US$) and Volume (Billion Tons), by Component (2021 – 2033)
    • Hardware
    • Software
    • Service
  • The Middle East and Africa AI in Precision Medicine Market Size Value (US$) and Volume (Billion Tons), by Therapeutic Application (2021 – 2033)
    • Oncology
    • Neurology
    • Cardiology
    • Respiratory
    • Others

Company Profiles

  • IBM
    • Company Overview
    • Geographic Footprints
    • Financial Performance
    • Product Portfolio
    • SWOT Analysis
    • R&D Efforts
    • Recent Developments & Strategic Collaborations
      • Product Launch/M&A/Technical Collaboration
  • Microsoft
  • Google
  • NVIDIA
  • Illumina
  • Roche
  • Johnson & Johnson
  • GE Healthcare
  • Intel Corporation
  • AstraZeneca
  • Sanofi
  • Tempus

Conclusion & Recommendations

  • Insight Code: 5080
  • No. of Pages: 150+
  • Format: PDF/PPT/Excel
  • Published: May 2025
  • Report Covered: [Revenue + Volume]
  • Historical Year: 2021-2022
  • Base Year: 2023
  • Estimated Years: 2024-2033

About The Author

Rohan Patil is a seasoned market research professional with over 5 years of focused experience in the healthcare sector, bringing deep domain expertise, strategic foresight, and analytical precision to every project he undertakes.

He began his journey with Precedence Research, where he played a pivotal role in developing high-impact healthcare market reports. Today, Rohan leads research initiatives at Towards Healthcare, while also contributing to Statifacts, where he supports cross-industry analysis and data-driven storytelling.

Rohan’s core strengths lie in trend analysis and emerging technologies, regulatory monitoring and thought leadership through high-quality report writing. He excels at identifying future-ready opportunities and translating complex data into strategic recommendations. His work spans pharmaceuticals, biotechnology, medical devices, and digital health, assessing everything from market potential and competitive positioning to customer needs and regulatory shifts.

A trusted advisor and a relentless innovator, Rohan continues to push the boundaries of traditional market research, merging scientific rigor with commercial insight to stay ahead in a fast-evolving healthcare landscape.

FAQ's

Key market players, including IBM, Microsoft, Google, NVIDIA, Illumina, Roche, Johnson & Johnson, GE Healthcare, Intel Corporation, AstraZeneca, Sanofi, Tempus are key market players contributing significantly to the growth of AI in cardiology.

Advancement in machine learning fostering growth of AI in precision market and AI driven innovation in cancer detection has contributed to the growth of the AI in precise medicine market, marking a significant advancement in personalized healthcare.

In the market for precision medicine, AI was dominated by North America. This area has a thriving network of academic institutions and medical facilities working together to use artificial intelligence (AI) to improve patient outcomes, personalized treatment plans, and diagnostic accuracy. Google, IBM Watson, Johnson and Johnson, and NIVIDIA.

National Institute of Health, National Cancer Institutes (NCI) Surveillance, American Cancer Society, Center for Disease Control and Prevension, World Health Organisation, EPRS | European Parliamentary Research Service, American College of Cardiology Foundation, Elsevier Publication.